Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
13.39
+0.12 (0.90%)
Mar 2, 2026, 4:00 PM EST - Market closed
Arvinas Market Cap
Arvinas has a market cap or net worth of $856.44 million as of March 3, 2026. Its market cap has decreased by -29.52% in one year.
Market Cap
856.44M
Enterprise Value
179.94M
1-Year Change
-29.52%
Ranking
Category
Stock Price
$13.39
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $856.44M, an increase of 65.93%. That is a compound annual growth rate of 7.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 856.44M | 12.44% |
| Dec 31, 2025 | 761.70M | -42.17% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phathom Pharmaceuticals | 903.03M |
| Xencor | 900.60M |
| Arbutus Biopharma | 898.15M |
| SpyGlass Pharma | 890.57M |
| UroGen Pharma | 890.31M |
| SELLAS Life Sciences Group | 859.92M |
| Omeros | 849.39M |
| Prime Medicine | 825.00M |